Vasodilator treatment for acute and chronic heart failure.
about
Clinical importance of the renin-angiotensin system in chronic heart failure: double blind comparison of captopril and prazosin.Treatment of chronic heart failure with pirbuterol: acute haemodynamic responses.Bedside haemodynamic monitoring: experience in a general hospital.Acute haemodynamic comparison of amrinone and pirbuterol in chronic heart failure. Additional effects of isosorbide dinitrate.Salbutamol in treatment of heart failure.Haemodynamic effects of nifedipine in heart failure.Salbutamol in cardiogenic shock complicating acute myocardial infarction.Circulatory effects of controlled arterial hypotension with trimetaphan (Arfonad). Experimental study in patients with left ventricular failureHydrallazine alone in acute left ventricular failure.A comparison of the effects of hydrallazine, diazoxide, sodium nitrite and sodium nitroprusside on human isolated arteries and veins.Modern treatment of heart failure.Cutaneous administration of nitroglycerin: a review.Cardiovascular effects of prenalterol on rest and exercise haemodynamics in patients with chronic congestive cardiac failure.Effects of sodium nitroprusside upon cardiac work, efficiency, and substrate extraction in severe left ventricular failure.Beneficial effects of captopril in left ventricular failure in patients with myocardial infarction.Vasodilatation in the treatment of congestive heart failure.Deliberate arterial hypotension in plastic surgery for the reduction of hypertrophic breast: a critical appraisal of surgical ischaemia and haemodynamic changes during sodium nitroprusside infusion.
P2860
Q34487124-E1AD8C3C-EF41-4CB0-B249-DD4D4564DD58Q34778812-6DD3D7F9-01A8-4E02-9D95-94AC31AA3633Q34994157-0CDE06A8-A979-4D56-8505-DB5E6C4AAA37Q36743146-87938025-F6B1-4441-AE10-58F800221F40Q36770781-6F896691-6907-46A1-A077-37B3B577DBB3Q36772026-B390D959-374B-404A-86BD-011C5EBC62C3Q36772896-26FDB5F2-B470-4129-9994-BB665E163DF1Q36788238-D39AD994-6D8C-4CB3-82DA-B872EB56D06BQ39107752-E79B9A5A-B634-42F2-85D0-ADF5E4B43242Q39361965-AE4C549E-DAA4-4E63-BF13-A8D152A5B9DFQ39517622-1F4FF856-BDE7-4658-88D8-CB3CD71B1580Q40208186-B758CF81-E1B4-4CA7-8002-DF000C991F7BQ41300220-77701282-A4B1-46F7-8610-0D7FD3D66B80Q41322354-CDD4A483-4B1E-4E9F-AEDD-8E6CA8821D0BQ41850226-944D4587-6FD9-4845-B5B8-2D6893153753Q46519295-418BC12C-4AE7-4677-A2BB-A1152984126DQ51878488-28EB4A78-5161-445D-9823-92EDDAA2C790
P2860
Vasodilator treatment for acute and chronic heart failure.
description
1977 nî lūn-bûn
@nan
1977年の論文
@ja
1977年学术文章
@wuu
1977年学术文章
@zh-cn
1977年学术文章
@zh-hans
1977年学术文章
@zh-my
1977年学术文章
@zh-sg
1977年學術文章
@yue
1977年學術文章
@zh
1977年學術文章
@zh-hant
name
Vasodilator treatment for acute and chronic heart failure.
@en
type
label
Vasodilator treatment for acute and chronic heart failure.
@en
prefLabel
Vasodilator treatment for acute and chronic heart failure.
@en
P2860
P356
P1476
Vasodilator treatment for acute and chronic heart failure.
@en
P2093
Chatterjee K
Parmley WW
P2860
P304
P356
10.1136/HRT.39.7.706
P577
1977-07-01T00:00:00Z